Microbiota: Overview and Implication in Immunotherapy-Based Cancer Treatments
During the last few years, the gut microbiota has gained increasing attention as a consequence of its emerging role as a modulator of the immune system. With the advent of the era of checkpoint inhibitors immunotherapy and adoptive cell transfer (ACT) in oncology, these findings became of primary re...
Main Authors: | Giovanni Brandi, Giorgio Frega |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-05-01
|
Series: | International Journal of Molecular Sciences |
Subjects: | |
Online Access: | https://www.mdpi.com/1422-0067/20/11/2699 |
Similar Items
-
Adoptive Cell Therapy in Breast Cancer: A Current Perspective of Next-Generation Medicine
by: Jesús Fuentes-Antrás, et al.
Published: (2020-10-01) -
Adoptive Immunotherapy beyond CAR T-Cells
by: Aleksei Titov, et al.
Published: (2021-02-01) -
Gut microbiome and CAR-T therapy
by: Muhammad Bilal Abid, et al.
Published: (2019-11-01) -
CAR-T “the living drugs”, immune checkpoint inhibitors, and precision medicine: a new era of cancer therapy
by: Delong Liu
Published: (2019-11-01) -
The promise of adoptive cellular immunotherapies in hepatocellular carcinoma
by: Peter G. Hendrickson, et al.
Published: (2020-01-01)